January 15, 2021

(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) is announcing two new additions to its Regulatory Affairs and Research teams.

Debjani Mukherjee joins PCMA as a Senior Director of Regulatory Affairs. Debjani comes to PCMA from the Planned Parenthood Association, where she served as Director of Public Policy and Government Relations. She has a wealth of regulatory experience, including positions with the National Quality Forum and several physician specialty groups working on quality measures and value-based payment. She started her career in basic and clinical research at the University of Pennsylvania and has worked on a wide variety of topics, including the biosimilar approval pathway, FDA drug submissions, FDA medical device user fees and social determinants of health. A significant portion of her career has focused on research, guideline recommendation development and quality measure development methodology.

Brianna Jones is joining PCMA as a Manager of Research. She will significantly expand our research and rapid-response capacity. Most recently, Brianna was a health policy analyst at Patients for Affordable Drugs, and she also worked with the Government Accountability Office and Blue Cross Blue Shield Association. She recently received her master’s degree in Public Policy from The George Washington University.

“We are thrilled to welcome Debjani and Brianna to our PCMA team,” said JC Scott, President and CEO of PCMA. “Their knowledge and experience will be great assets to PCMA’s work representing PBMs as they provide prescription drug access and affordability to millions of patients nationwide.”